India’s healthcare sector is changing quickly through new ideas. This includes better medicines, health technologies, vaccines, biotech, and medical devices. Together, these make up about 15 percent of India’s total healthcare market. This innovation market is expected to grow to about $60 billion by 2028.
The main areas driving this growth are pharma services and healthtech. Together, they make up around 75 percent of the innovation market. Pharma services alone cover about 50 percent. Many of these services focus on exporting to other countries. This trend is linked to a strategy called “China + 1.” This means some companies move work to India from China because it is cheaper and the country has skilled workers and good policies.
The healthtech sector has also grown quickly. It almost doubled from $3 billion in 2020 to $7 billion in 2023. This sector includes telemedicine services, online pharmacies, digital wellness apps, and software for healthcare companies. The COVID-19 pandemic helped speed up the use of digital health by forcing many services to move online.
India’s vaccine and biotech industry is worth about $4 billion. It makes vaccines for about 60 percent of the world’s needs. This sector is now working on new therapies like mRNA and DNA vaccines, plus advanced treatments like gene and cell therapy. The medical technology field is smaller, at around $11 billion, but is shifting from mainly importing to creating new tools. These include AI-supported diagnostic devices and local products.
Healthcare leaders and IT managers in the United States should understand these changes for several reasons.
First, many U.S. healthcare companies work with or outsource services to Indian firms. This includes drug development, manufacturing, research, software, and telehealth. India is becoming a trusted and low-cost partner for these services. This opens new chances for U.S. healthcare to get advanced technologies and services with lower costs.
Second, healthtech growth in India shows new technologies that U.S. healthcare can use. For example, software that helps manage patient communication, automate office tasks, or use AI to support clinical decisions is growing fast in India. U.S. healthcare providers can partner with or buy such technologies to improve efficiency and patient care.
Third, Indian startups and larger companies are reaching smaller cities and underserved populations. Their work in scaling digital health solutions for many different people can offer useful lessons for rural and underserved areas in the U.S.
A key part of healthcare innovation is using artificial intelligence (AI) and automation to make healthcare work easier and better. AI is being used for patient scheduling, answering calls, managing records, and billing. These tasks are very important in healthcare administration.
Simbo AI is a company working on automating front-office phone calls using AI. This technology helps healthcare providers handle many patient calls, appointment requests, and follow-ups more easily.
For U.S. healthcare managers, AI phone systems can reduce the work for staff by answering regular questions and booking appointments. This lowers patient wait times and missed calls. The result is happier patients and smoother office work. AI can also connect with electronic health records (EHR) and management software to give personal replies and reminders, which improves care coordination.
India’s healthcare innovation shows clear benefits of using AI and automation. Companies in India use AI combined with digital platforms to handle complex healthcare communications. Both startups and big pharmaceutical firms use AI to speed up drug development and production. This affects medicine availability and costs worldwide.
AI and automation also help analyze patient data and support diagnosis. Indian medical technology companies create AI tools that help doctors find diseases early through imaging and pattern recognition. Such tools can help U.S. providers improve diagnosis and reduce delays.
In healthcare administration, AI can take over routine tasks like insurance checks, claims processing, and patient intake forms. This free time lets staff focus on harder tasks and better patient care.
The healthcare innovation market in India is worth about $30 billion now and is expected to grow a lot in the next years. Pharma services and healthtech lead this growth. The market gains from global trends, government policies, and advances in technology like AI and machine learning.
For healthcare providers in the U.S., these changes are important. Working with Indian pharma and healthtech companies can lower costs and give access to new technology. Also, AI-based automation and digital health services made in India can serve as examples for U.S. healthcare to improve how they work and help patients.
As healthcare systems connect more worldwide, it is important for U.S. healthcare leaders and IT managers to watch these global changes. This helps them make better decisions that improve patient care and run their practices better.
Healthcare innovation in India is currently valued at approximately $30 billion, representing about 15% of the overall healthcare market, which reached around $180 billion in FY 2023.
Advancements in AI foundational models will drive significant changes across R&D, manufacturing, supply chain management, and healthcare delivery, facilitating new solutions and reshaping operational efficiencies.
Key segments contributing to growth include pharma services, healthtech, vaccines and biotech, and medtech, which together are projected to account for around 80% of the healthcare innovation market by FY 2028.
The consumerization of health has been accelerated by Covid-19, with consumers increasingly seeking convenience and quality care, driving growth in healthtech products and services.
Pharma companies are shifting their outsourcing strategies to reduce costs and time to market, increasing their reliance on countries like India for drug discovery and manufacturing.
India’s growing scientific and technological expertise, particularly in AI, advanced analytics, and AR/VR, positions it as a pivotal hub for innovation in pharma and healthcare services.
Government initiatives for digital health, including the Ayushman Bharat Digital Mission, aim to improve healthcare digitization and accessibility, which is crucial for fostering innovation.
The healthcare innovation market is projected to grow to approximately $60 billion by FY 2028, driven primarily by advancements in pharma services and healthtech.
Investor interest is shifting toward segments with positive unit economics, especially in pharma services, while also exploring emerging sectors like medtech and biotech.
Critical challenges include streamlining regulatory approval processes, effective implementation of government policies, and facilitating collaboration between healthcare incumbents and new entrants.